HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Val M Runge Selected Research

gadoterate meglumine

11/2012MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
6/2012Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
5/2010Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
3/2010Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
5/2009Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Val M Runge Research Topics

Disease

11Glioma (Gliomas)
03/2011 - 01/2004
8Neoplasms (Cancer)
10/2023 - 05/2002
8Nephrogenic Fibrosing Dermopathy
10/2018 - 02/2007
8Brain Neoplasms (Brain Tumor)
03/2011 - 01/2004
7Body Weight (Weight, Body)
01/2013 - 01/2004
3Renal Artery Obstruction (Renal Artery Stenosis)
09/2012 - 04/2006
3Neoplasm Metastasis (Metastasis)
04/2007 - 05/2002
1Pain (Aches)
10/2018
1Infections
12/2013
1Prosthesis Failure
12/2013
1Aneurysm (Aneurysms)
11/2012
1Pathologic Constriction (Stenosis)
06/2012
1Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2010
1Acidosis
02/2007
1Necrosis
07/2002
1Inflammation (Inflammations)
07/2002
1Edema (Dropsy)
07/2002

Drug/Important Bio-Agent (IBA)

16GadoliniumIBA
10/2023 - 01/2004
11Contrast MediaIBA
01/2017 - 04/2006
8gadobutrolIBA
01/2013 - 05/2009
8Gadolinium DTPA (Magnevist)FDA Link
03/2011 - 07/2002
5gadoterate meglumineIBA
11/2012 - 05/2009
5gadobenic acid (gadobenate dimeglumine)FDA Link
04/2007 - 05/2002
4gadodiamide (Omniscan)FDA Link
12/2010 - 05/2002
2gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
06/2012 - 04/2009
2PlasticsIBA
12/2010 - 05/2010
1CollagenIBA
10/2023
1Durapatite (Hydroxylapatite)IBA
10/2018
1MetalsIBA
12/2013
1FibrinIBA
03/2011
1Peptides (Polypeptides)IBA
03/2011
1EP-2104RIBA
03/2011
1A-factor (Streptomyces)IBA
04/2009
1AlbuminsIBA
02/2009
1Pentetic Acid (DTPA)FDA LinkGeneric
04/2007
1Bicarbonates (Hydrogen Carbonate)IBA
02/2007
1gadoversetamide (OptiMARK)FDA Link
07/2002
1gadoteridol (Prohance)FDA Link
07/2002
1Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric
07/2002

Therapy/Procedure

2Cannula
12/2010 - 05/2010
1Catheters
06/2012
1Deep Brain Stimulation
12/2010
1Injections
04/2009